معرفی
Wei Wang is a Research Associate Professor at the University of Houston College of Pharmacy in the Department of Pharmacological and Pharmaceutical Sciences. His research focuses on oncogene regulation, drug development, and translational cancer therapies.
Education:
- Ph.D. in Molecular Pharmacology, Fudan University School of Pharmacy, China
- B.M. (MD equivalent) with Honor, Changzhi Medical College, China
Research Interests:
- MDM2 oncogene inhibition
- Cancer chemotherapy
- Antisense therapy and gene silencing
- Translational drug development
- Preclinical models for brain tumors, neuroblastoma, and hepatocellular carcinoma
Publications Trends: Wei Wang's research over 17 years (2007-2020) centers on MDM2 inhibition across multiple cancers, including brain tumors, prostate cancer, pancreatic cancer, and breast cancer. His work explores both synthetic and natural compounds, with a focus on p53-independent mechanisms and dual-target therapies (e.g., MDM2-NFAT1 inhibition).
Contact: wwang45@uh.edu
۰مقاله منتشرشده
